Gadoteridol

Suppliers

Names

[ CAS No. ]:
120066-54-8

[ Name ]:
Gadoteridol

[Synonym ]:
prohance
Indole-3-carboxaldoxiMe
gadolinium-hp-do3a
gd-hp-do3a
Gd(III) 1-(4,7,10-triscarboxymethyl-(1,4,7,10-tetraazacyclododecyl))-2-methyl-ethoxy
Gadoteridol
2-(Acetoxy)thiobenzaMide
3-(Acetoxy)thiobenzaMide
Gd-10-(2-hydroxy-propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate

Chemical & Physical Properties

[ Boiling Point ]:
668.2ºC at 760 mmHg

[ Melting Point ]:
>225ºC

[ Molecular Formula ]:
C17H28GdN4O7

[ Molecular Weight ]:
557.67700

[ Flash Point ]:
357.9ºC

[ Exact Mass ]:
558.12000

[ PSA ]:
101.09000

[ Vapour Pressure ]:
1.04E-20mmHg at 25°C

[ Storage condition ]:
2-8℃

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LW4430000
CHEMICAL NAME :
Gadolinium, (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane- 1,4,7-triacetato(3-)- N(sup 1),N(sup 4),N(sup 7),N(sup 10),O(sup 1),O(sup 4),O(sup 7),O(sup 10))-
CAS REGISTRY NUMBER :
120066-54-8
LAST UPDATED :
199503
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C17-H29-Gd-N4-O7
MOLECULAR WEIGHT :
558.75

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5587 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 17,187,1992
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
6146 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 17,187,1992

Safety Information

[ RIDADR ]:
NONH for all modes of transport

Related Compounds

  • Gadoteridol impurity
  • Desgadolinium Gadoteridol
  • Des(2-Hydroxypropyl) Gadoteridol
  • 7-chloro-N-(3-methoxyphenyl)thiazolo[5,4-d]pyrimidin-2-amine
  • 2-(m-Tolylthio)-6-chloropyridine
  • 4-[[4-Chloro-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzoyl chloride
  • Methyl 5-bromo-7-methoxybenzofuran-2-carboxylate
  • 2-(2-(Pyrrolidin-1-yl)ethoxy)-6-chloropyrazine
  • 1-(3-(4-methoxybenzylcarbamoyl)-1H-pyrazol-4-yl)urea
  • 2-(3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl)-N-(prop-2-ynyl)acetamide
  • (R)-1-Benzoyl-4-(4-iodophenyl)sulfonyl-3-methylpiperazine
  • 3-(5-((2-ethyl-1H-imidazol-1-yl)methyl)-1,2,4-oxadiazol-3-yl)benzaldehyde
  • Ethyl 6-bromo-1,4-dihydro-7-methyl-4-oxoquinoline-3-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.